VERSED
MIDAZOLAM HYDROCHLORIDE
Approval overview VERSED is listed in Drugs@FDA under application 018654 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HLR Submission history Latest submission status date: 2001-09-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview VERSED is listed in Drugs@FDA under application 018654 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HLR Submission history Latest submission status date: 2001-09-04 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.